AUVEN THERAPEUTICS HOLDINGS LP filings

This page lists the SEC filings reported by AUVEN THERAPEUTICS HOLDINGS LP.

SEC filings by AUVEN THERAPEUTICS HOLDINGS LP (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13D/A2024-04-25AUVEN THERAPEUTICS HOLDINGS LPADC Therapeutics SA2,231,2102.7%EDGAR
SC 13D/A2023-04-28AUVEN THERAPEUTICS HOLDINGS LPADC Therapeutics SA6,330,5487.9%EDGAR
SC 13D/A2023-02-06AUVEN THERAPEUTICS HOLDINGS LPADC Therapeutics SA6,330,5487.9%EDGAR
SC 13D/A2022-12-23AUVEN THERAPEUTICS HOLDINGS LPADC Therapeutics SA18,330,54823.8%EDGAR
SC 13D/A2022-12-09AUVEN THERAPEUTICS HOLDINGS LPADC Therapeutics SA18,330,54823.8%EDGAR
SC 13D/A2022-12-08AUVEN THERAPEUTICS HOLDINGS LPADC Therapeutics SA21,418,73027.8%EDGAR
SC 13D/A2020-10-13AUVEN THERAPEUTICS HOLDINGS LPADC Therapeutics SA22,193,73028.9%EDGAR
SC 13D2020-05-29AUVEN THERAPEUTICS HOLDINGS LPADC Therapeutics SA23,593,73033.4%EDGAR
Form 13F-HR
The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
Form SC 13D/G
Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
Form 3, 4, and 5
Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.